Professionals
Labiana |
4 August
Labiana Health, the Spanish pharmaceutical group specializing in human and animal health, has published a communication through BME Growth, the Spanish alternative stock market where it is listed, disclosing an unaudited preliminary report on its consolidated financial results for the first half of the fiscal year in 2025.
Labiana |
11 October
The company responds to this growing need by reinforcing the products offer in companion animals range. Taking into account that
Labiana |
14 March
Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha reforzado su división especializada en pequeños animales.
Ataxxa, distribuido por Labiana, autorizado para la reducción del riesgo de infección por Leishmania
Labiana |
17 February
Ataxxa, medicamento distribuido por Labiana, autorizado para la reducción del riesgo de infección por Leishmania.
Labiana |
12 May
One of the main products we developed within our strategic plan of organic growth. We invested in purchasing new assets,